- Home
- MRM vs SNOA Comparison
MRM vs SNOA Comparison
Compare MRM & SNOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRM
- SNOA
- Stock Information
- Founded
- MRM 2000
- SNOA 1999
- Country
- MRM Japan
- SNOA United States
- Employees
- MRM N/A
- SNOA N/A
- Industry
- MRM Other Consumer Services
- SNOA Biotechnology: Pharmaceutical Preparations
- Sector
- MRM Consumer Discretionary
- SNOA Health Care
- Exchange
- MRM Nasdaq
- SNOA Nasdaq
- Market Cap
- MRM 5.9M
- SNOA 6.4M
- IPO Year
- MRM 2020
- SNOA 2007
- Fundamental
- Price
- MRM $1.36
- SNOA $2.90
- Analyst Decision
- MRM
- SNOA
- Analyst Count
- MRM 0
- SNOA 0
- Target Price
- MRM N/A
- SNOA N/A
- AVG Volume (30 Days)
- MRM 44.6K
- SNOA 33.3K
- Earning Date
- MRM 05-20-2025
- SNOA 06-17-2025
- Dividend Yield
- MRM N/A
- SNOA N/A
- EPS Growth
- MRM 27.65
- SNOA N/A
- EPS
- MRM 0.18
- SNOA N/A
- Revenue
- MRM $52,786,758.00
- SNOA $14,288,000.00
- Revenue This Year
- MRM N/A
- SNOA $38.54
- Revenue Next Year
- MRM N/A
- SNOA N/A
- P/E Ratio
- MRM $8.41
- SNOA N/A
- Revenue Growth
- MRM 21.55
- SNOA 12.20
- 52 Week Low
- MRM $0.34
- SNOA $1.75
- 52 Week High
- MRM $8.39
- SNOA $9.37
- Technical
- Relative Strength Index (RSI)
- MRM 49.70
- SNOA 38.85
- Support Level
- MRM $1.32
- SNOA $2.81
- Resistance Level
- MRM $1.50
- SNOA $3.45
- Average True Range (ATR)
- MRM 0.09
- SNOA 0.13
- MACD
- MRM -0.05
- SNOA -0.05
- Stochastic Oscillator
- MRM 18.92
- SNOA 10.77
About MRM MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.
About SNOA Sonoma Pharmaceuticals Inc.
Sonoma Pharmaceuticals Inc is a specialty pharmaceutical company operating in the United States. It is engaged in identifying, developing, and commercializing differentiated therapies for patients living with chronic skin conditions. The company focuses on the development and commercialization of therapeutic solutions in medical dermatology to treat skin conditions, such as acne, atopic dermatitis, and scarring. The key products of the company are Celacyn, Ceramax Skin Barrier Cream, Mondoxyne, Alevicyn, SebuDerm, Microcyn, and Microcyn which are available for various skin treatments such as scars, itchy skin, minor skin irritations, rashes, and others. The company derives revenue from the sale of products in the United States, Latin America, Europe, Asia, and other countries.